EQV Ventures Acquisition Corp II is a US-based company operating in industry. The company is headquartered in Park City, Utah. The company went IPO on 2025-07-02. EQV Ventures Acquisition Corp. II is a blank check company. The firm is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company intends to focus its search for a target business in the energy industry. The firm is not engaged in any operations nor generated any revenues.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Revenue
0
0
0
0
Revenue Growth (YoY)
--
--
--
--
Cost of Revenue
--
--
0
0
Gross Profit
--
--
0
0
Selling, General & Admin
0
0
0
0
Research & Development
0
--
--
--
Operating Expenses
1
0
0
0
Other Non Operating Income (Expenses)
0
0
0
0
Pretax Income
-1
0
0
0
Income Tax Expense
--
--
--
--
Net Income
-1
0
0
0
Net Income Growth
--
--
--
--
Shares Outstanding (Diluted)
25.59
27.75
27.75
42
Shares Change (YoY)
--
0%
-34%
--
EPS (Diluted)
-0.05
-0.01
0
0
EPS Growth
--
1,757%
40%
--
Free Cash Flow
-10
0
0
0
Free Cash Flow Per Share
--
--
--
--
Gross Margin
--
--
0%
0%
Operating Margin
0%
0%
0%
0%
Profit Margin
0%
0%
0%
0%
Free Cash Flow Margin
0%
0%
0%
0%
EBITDA
--
--
--
--
EBITDA Margin
--
--
--
--
D&A For EBITDA
--
--
--
--
EBIT
-1
0
0
0
EBIT Margin
0%
0%
0%
0%
Effective Tax Rate
--
--
--
--
Follow-Up Questions
What are EQV Ventures Acquisition Corp II's key financial statements?
According to the latest financial statement (Form-10K), Curanex Pharmaceuticals Inc has a total asset of $0, Net loss of $0
What are the key financial ratios for EVAC?
Curanex Pharmaceuticals Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is EQV Ventures Acquisition Corp II's revenue broken down by segment or geography?
Curanex Pharmaceuticals Inc largest revenue segment is Digital Marketing, at a revenue of 237,868 in the most earnings release.For geography, Great Britain is the primary market for Curanex Pharmaceuticals Inc, at a revenue of 122,184.
Is EQV Ventures Acquisition Corp II profitable?
no, according to the latest financial statements, Curanex Pharmaceuticals Inc has a net loss of $0
Does EQV Ventures Acquisition Corp II have any liabilities?
no, Curanex Pharmaceuticals Inc has liability of 0
How many outstanding shares for EQV Ventures Acquisition Corp II?
Curanex Pharmaceuticals Inc has a total outstanding shares of 27.75